Consequently, ONC212 (a fluorinated imipridone), a GRP78 modulator, and AG1024 (IGF-R inhibitor), induce a synergistic anti-cancer effect with apoptotic PANC-1 cells that survived each drug individually [89]. Here, HSPA5 is linked to cancer.